Companies › KARD

KARD 10-K & 10-Q changes, risk factors and insider trading

Kardigan, Inc. · Nasdaq · Pharmaceutical Preparations · CIK 2123613 · All filings on SEC.gov

Everything below is quoted or computed from Kardigan, Inc.'s public SEC filings. It is not a recommendation to buy or sell. Automated comparisons can contain errors; confirm with the original filing.

At a glance

3Form 4 filings reporting open-market purchases (last 180 days)
0Form 4 filings reporting open-market sales (last 180 days)

Jump to: Annual report (10-K) · Quarterly report (10-Q) · Insider transactions · 13F holders

What changed in the latest 10-K

Comparison not available: Not available: fewer than two 10-K filings on EDGAR to compare..

What changed in the latest 10-Q

Comparison not available: Not available: fewer than two 10-Q filings on EDGAR to compare (only one so far)..

KARD insider buying and selling (Form 4)

Since 2026-04-11, insiders reported open-market purchases in 3 Form 4 filings (3 insiders, 1 trade date, 5,625,000 shares, about $90.0M) and open-market sales in 0 filings. Net open-market shares: 5,625,000 (purchases minus sales); net value about $90.0M.Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.

Trade dateInsiderTransactionSharesPriceValueOwned afterFiling
2026-06-22Hrtg Pv, L.p.
10% owner		 Open-market purchase 3,125,000$16.00 $50.0M14,866,868 SEC
2026-06-22Berns Paul L
Director, 10% owner		 Open-market purchase 1,250,000$16.00 $20.0M15,042,035 SEC
2026-06-22Nelsen Robert
Director, 10% owner		 Open-market purchase 1,250,000$16.00 $20.0M15,042,035 SEC
2026-06-17Edelman Joseph
Director		 Grant/award 20,706— —20,706 SEC
2026-06-17Johnson Keith Bryon
10% owner		 Conversion 2,050,166— —2,050,166 SEC
2026-06-17Johnson Keith Bryon
10% owner		 Conversion 6,150,502— —6,150,502 SEC
2026-06-17Johnson Keith Bryon
10% owner		 Conversion 3,242,993— —9,393,495 SEC
2026-06-17Johnson Keith Bryon
10% owner		 Conversion 2,348,373— —11,741,868 SEC
2026-06-17Nelsen Robert
10% owner		 Conversion 13,792,035— —13,792,035 SEC
2026-06-17Pasternak Andy
Chief Strategy Officer		 Grant/award 79,640— —79,640 SEC
2026-06-17Meeker David P
Director		 Grant/award 20,706— —20,706 SEC
2026-06-17Berns Paul L
Director, 10% owner		 Conversion 13,792,035— —13,792,035 SEC
2026-06-17Berns Paul L
Director, 10% owner		 Grant/award 20,706— —20,706 SEC
2026-06-17Moriarty John B
Chief Legal Officer		 Grant/award 47,784— —47,784 SEC
2026-06-17Jahn Brianne
Chief Financial Officer		 Grant/award 79,640— —79,640 SEC
2026-06-17Popovits Kimberly J
Director		 Grant/award 20,706— —20,706 SEC
2026-06-17Walbert Timothy P
Director		 Grant/award 20,706— —20,706 SEC
2026-06-17Gianakakos Anastasios
Director, President & CEO		 Conversion 498,692— —498,692 SEC
2026-06-17Gianakakos Anastasios
Director, President & CEO		 Conversion 28,702— —5,665,090 SEC
2026-06-17Gianakakos Anastasios
Director, President & CEO		 Conversion 41,001— —2,422,520 SEC
2026-06-17Giordano Douglas E.
Director		 Grant/award 20,706— —20,706 SEC
2026-06-17Edelberg Jay
Chief Medical Officer		 Grant/award 47,784— —183,327 SEC
2026-06-17Edelberg Jay
Chief Medical Officer		 Conversion 97,587— —135,543 SEC

Well-known investors holding KARD (13F)

InvestorQuarterSharesReported value% of their 13FChange vs prior quarter
Millennium Management (Israel Englander) COM2026-06-30223,065$5.3M0.0%New position
Citadel Advisors (Ken Griffin) COM2026-06-30120,000$2.9M0.0%New position
D. E. Shaw & Co. COM2026-06-3015,000$357.8K0.0%New position
Soros Fund Management COM2026-06-3015,000$357.8K0.0%New position
Two Sigma Investments COM2026-06-3012,500$298.1K0.0%New position
Point72 Asset Management (Steve Cohen) COM2026-06-3012,386$295.4K0.0%New position

13F reports are filed up to 45 days after quarter end and show long U.S. equity positions only; options positions are omitted here.

Coming soon: email alerts when KARD files, watchlists and downloadable comparisons.